NM_005227.3:c.372C>G

Variant summary

Our verdict is Uncertain significance.
+1 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 1 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Supporting

The NM_005227.3(EFNA4):c.372C>G (p.Phe124Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene EFNA4 is a known oncogene (CancerMine: 4 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000205 (AC=3) in the gnomAD database across 1,460,516 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000003. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.F124= (synonymous): Benign/Likely_benign (ClinVar VariationId 710307, 2 stars)

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

EFNA4
NM_005227.3 missense

Scores

8
9
1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.06

Publications

10 publications found
Variant links:
Genes affected
EFNA4 (HGNC:3224): (ephrin A4) This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin that has been implicated in proliferation and metastasis of several types of cancers. [provided by RefSeq, May 2022]
EFNA4 Gene-Disease associations (from GenCC):
  • craniosynostosis
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005227.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000000 — very rare (O3 supporting [+1])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_005227.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

EFNA4 NM_005227.3
MANE Select
HGVSc / HGVSpc.372C>Gp.Phe124Leu
Exon rankExon 2 of 4
missense
Prot: NP_005218.1UniProt: P52798-1
EFNA4 NM_182689.2
HGVSc / HGVSpc.372C>Gp.Phe124Leu
Exon rankExon 2 of 4
missense
Prot: NP_872631.1UniProt: P52798-3
EFNA4 NM_182690.3
HGVSc / HGVSpc.372C>Gp.Phe124Leu
Exon rankExon 2 of 4
missense
Prot: NP_872632.2UniProt: P52798-2

Ensembl Transcripts

EFNA4 ENST00000368409.8
TSL:1MANE Select
HGVSc / HGVSpc.372C>Gp.Phe124Leu
Exon rankExon 2 of 4
missense
Prot: ENSP00000357394.3UniProt: P52798-1
EFNA4 ENST00000359751.8
TSL:1
HGVSc / HGVSpc.372C>Gp.Phe124Leu
Exon rankExon 2 of 4
missense
Prot: ENSP00000352789.4UniProt: P52798-2
EFNA4-EFNA3 ENST00000505139.1
TSL:2
HGVSc / HGVSpc.113+3052C>G
Exon rankIntron 1 of 4
intron
Prot: ENSP00000426741.1UniProt: K9J7H7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
Cov:32
GnomAD2 exomes
AF: 0.00000801
AC:2
AN:249734
GnomAD4 exome
AF: 0.00000205
AC:3
Hom:0
AN:1460516
Cov:32
GnomAD4 genome
Cov:32
Local & regional cohorts 1 source
Turkish Variome
AF: 0.000178
AC:1
Hom:0
AN:5138
Showing 5 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Pathogenic25
AlphaMissense
Pathogenic1.0
BayesDel_addAF
Pathogenic0.26D
BayesDel_noAF
Pathogenic0.21
CADD
Uncertain23
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.89D
Eigen
Uncertain0.46
Eigen_PC
Uncertain0.32
FATHMM_MKL
Uncertain0.85D
FuncVEP CTI
Pathogenic0.89
GPN-Star LLR
N/A-8.8
GPN-Star score
N/A8.8
LIST_S2
Uncertain0.94D
M_CAP
Uncertain0.14D
MetaRNN
Pathogenic0.99D
MetaSVM
Benign-0.29T
Mutation Taster
N/A89/11polymorphism
MutationAssessor
Pathogenic3.5H
PhyloP100
Benign1.1
popEVE
Benign-3.8
PROVEAN
Pathogenic-5.9D
REVEL
Uncertain0.53
Sift
Uncertain0.0010D
Sift4G
Uncertain0.0060D
Varity_R
N/A0.82
VESM-3B
Benign-10
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.